Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 197.28 billion. The enterprise value is 216.05 billion.

Market Cap	197.28B
Enterprise Value	216.05B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.25%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.53B

Valuation Ratios

The trailing PE ratio is 21.77.

PE Ratio	21.77
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	45.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.67, with an EV/FCF ratio of 19.51.

EV / Earnings	23.84
EV / Sales	4.30
EV / EBITDA	11.67
EV / EBIT	14.38
EV / FCF	19.51

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.86.

Current Ratio	1.36
Quick Ratio	0.92
Debt / Equity	0.86
Debt / EBITDA	1.64
Debt / FCF	2.57
Interest Coverage	15.08

Financial Efficiency

Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 14.87%.

Return on Equity (ROE)	28.33%
Return on Assets (ROA)	10.53%
Return on Capital (ROIC)	14.87%
Revenue Per Employee	663,861
Profits Per Employee	127,657
Employee Count	72,000
Asset Turnover	0.56
Inventory Turnover	2.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.11%
50-Day Moving Average	54.50
200-Day Moving Average	64.01
Relative Strength Index (RSI)	51.34
Average Volume (20 Days)	403,919

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.89

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 47.13 billion and earned 9.06 billion in profits. Earnings per share was 3.57.

Revenue	47.13B
Gross Profit	36.10B
Operating Income	14.10B
Pretax Income	10.24B
Net Income	9.06B
EBITDA	17.11B
EBIT	14.10B
Earnings Per Share (EPS)	3.57

Full Income Statement

Balance Sheet

The company has 10.89 billion in cash and 28.45 billion in debt, giving a net cash position of -17.56 billion.

Cash & Cash Equivalents	10.89B
Total Debt	28.45B
Net Cash	-17.56B
Net Cash Per Share	n/a
Equity (Book Value)	33.25B
Book Value Per Share	13.11
Working Capital	8.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.63 billion and capital expenditures -2.55 billion, giving a free cash flow of 11.07 billion.

Operating Cash Flow	13.63B
Capital Expenditures	-2.55B
Free Cash Flow	11.07B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.59%, with operating and profit margins of 29.91% and 19.23%.

Gross Margin	76.59%
Operating Margin	29.91%
Pretax Margin	21.72%
Profit Margin	19.23%
EBITDA Margin	36.29%
EBIT Margin	29.91%
FCF Margin	23.49%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	63.72%
Buyback Yield	0.25%
Shareholder Yield	0.25%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.38.

Altman Z-Score	4.38
Piotroski F-Score	n/a